1 Min Read
Nov 7 (Reuters) - Rigel Pharmaceuticals Inc
* Rigel announces third quarter 2017 financial results and provides company update
* Q3 loss per share $0.14 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.